United Therapeutics (UTHR) got here out with quarterly earnings of $1.20 per share, lacking the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $3.34 per share a 12 months in the past. These figures are adjusted for non-recurring gadgets.
This quarterly report represents an earnings shock of -51.42%. 1 / 4 in the past, it was anticipated that this drugmaker would put up earnings of $2.34 per share when it truly produced earnings of $3.01, delivering a shock of 28.63%.
During the last 4 quarters, the corporate has surpassed consensus EPS estimates thrice.
United Therapeutics, which belongs to the Zacks Medical – Medicine trade, posted revenues of $311.10 million for the quarter ended December 2019, lacking the Zacks Consensus Estimate by 11.10%. This compares to year-ago revenues of $381.40 million. The corporate has topped consensus income estimates thrice during the last 4 quarters.
The sustainability of the…